全球生物药物注射装置市场 – 行业趋势及 2028 年预测

请求目录 请求目录 与分析师交谈 与分析师交谈 立即购买 立即购买 购买前请咨询 提前咨询 免费样本报告 免费样本报告

全球生物药物注射装置市场 – 行业趋势及 2028 年预测

  • Healthcare
  • Upcoming Report
  • Jan 2021
  • Global
  • 350 页面
  • 桌子數: 220
  • 图号: 60

全球生物药物注射装置市场,按产品类型(传统注射装置、其他)、应用(自身免疫性疾病、激素紊乱、孤儿病、美容治疗、其他临床应用)、最终用户(医院和诊所、家庭护理环境、其他)、给药部位(皮肤、循环/肌肉骨骼系统、器官、中枢神经系统)、可用性(可重复使用的笔式注射器、一次性笔式注射器)、国家(美国、加拿大、墨西哥、德国、意大利、英国、法国、西班牙、荷兰、比利时、瑞士、土耳其、俄罗斯、欧洲其他地区、日本、中国、印度、韩国、澳大利亚、新加坡、马来西亚、泰国、印度尼西亚、菲律宾、亚太其他地区、巴西、阿根廷、南美洲其他地区、南非、沙特阿拉伯、阿联酋、埃及、以色列、中东和非洲其他地区)行业趋势和预测到 2028 年

生物药物注射装置市场市场分析与洞察:全球生物药物注射装置市场

预计生物药物注射装置市场将在 2021 年至 2028 年的预测期内实现市场增长。Data Bridge Market Research 分析称,到 2028 年,市场规模将达到 7343.5 亿美元,在上述预测期内的复合年增长率为 12.58%。患者对生物药物益处的认识不断提高,这将有助于促进市场的增长。

注射装置适用于需要定期服用药物和激素以长期治疗糖尿病、类风湿性关节炎和其他慢性疾病的患者。自注射工具有可重复使用和一次性两种类型。自注射系统具有减少医院就诊次数、易于使用和低成本等优点。

慢性病患者数量激增、老年人口患病率上升、自我注射设备的使用率上升、政府优惠报销政策的日益普及、制药行业对生物制剂的使用率上升,这些是可能在 2021-2028 年预测期内促进生物药物注射设备市场增长的一些主要和重要因素。另一方面,患者依从性的提高、监管政策的宽松和技术进步的增加将进一步促进生物药物注射设备市场在上述预测期内的增长,从而创造巨大的机会。 

Introduction of alternative drug delivery methods along with increasing incidence of needlestick injuries and infections which will likely to act as market restraints factor for the growth of the injection devices for biological drugs in the above mentioned projected timeframe.  Strict regulation for patent approval which will become the biggest and foremost challenge for the growth of the market.

This injection devices for biological drugs market report provides details of new recent developments, trade regulations, import export analysis, production analysis, value chain optimization, market share, impact of domestic and localised market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on injection devices for biological drugs market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.

Global Injection Devices for Biological Drugs Market Scope and Market Size

Injection devices for biological drugs market is segmented on the basis of type of product, application, site of administration, usability, and end user. The growth amongst these segments will help you analyse meagre growth segments in the industries, and provide the users with valuable market overview and market insights to help them in making strategic decisions for identification of core market applications.

  • Based on type of product, the injection devices for biological drugs market is segmented into conventional injection devices, and others. Conventional injection devices have been further segmented into glass material, and plastic material. Plastic material has been further sub segmented into self-injection devices, needle-free injectors, autoinjectors, pen injectors, wearable injectors, and others.  
  • Injection devices for biological drugs market has also been segmented based on the end user into hospitals and clinics, home care settings, and others.
  • Based on application, the injection devices for biological drugs market is segmented into autoimmune diseases, hormonal disorders, orphan diseases, aesthetic treatment, and other clinical applications. Other clinical applications have been further segmented into pain management, allergies, cancer, hepatitis C, and haemophilia.  
  • On the basis of site of administration, the injection devices for biological drugs market is segmented into skin, circulatory/musculoskeletal system, organs, and central nervous system. Skin has been further segmented into intradermal, and subcutaneous. Circulatory/musculoskeletal system has been further segmented into intravenous, intracardiac, intramuscular, and intraperitoneal. Organs have been further segmented into intravitreal, and intra-articular. Central nervous system has been further segmented into intracerebral, and intrathecal.
  • Based on usability, the injection devices for biological drugs market is segmented into reusable pen injectors, and disposable pen injectors.

Injection Devices for Biological Drugs Market Country Level Analysis

Injection devices for biological drugs market is analysed and market size insights and trends are provided by country, type of product, application, site of administration, usability, and end user as referenced above.

The countries covered in the injection devices for biological drugs market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.

North America dominates the injection devices for biological drugs market due to the increasing incidence of chronic diseases along with rising demand of self-injection devices in the region, while Asia-Pacific is expected to grow at the highest growth rate in the forecast period of 2021 to 2028 due to the increasing levels of disposable income, rising occurrences of chronic diseases along with increasing awareness on safety and comfort.

The country section of the injection devices for biological drugs market report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points such as consumption volumes, production sites and volumes, import export analysis, price trend analysis, cost of raw materials, down-stream and upstream value chain analysis are some of the major pointers used to forecast the market scenario for individual countries. Also, presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.

Healthcare Infrastructure growth Installed base and New Technology Penetration

生物药物注射设备市场还为您提供每个国家/地区资本设备医疗保健支出增长的详细市场分析、生物药物注射设备市场不同类型产品的安装基数、使用生命线曲线的技术影响以及医疗保健监管情景的变化及其对生物药物注射设备市场的影响。数据适用于 2010 年至 2019 年的历史时期。

生物药物注射装置市场竞争格局及份额分析

生物药物注射装置市场竞争格局按竞争对手提供详细信息。详细信息包括公司概况、公司财务状况、收入、市场潜力、研发投资、新市场计划、全球影响力、生产基地和设施、生产能力、公司优势和劣势、产品发布、产品宽度和广度、应用主导地位。以上提供的数据点仅与公司对生物药物注射装置市场的关注有关。

生物药品注射设备市场报告涵盖的主要参与者包括 Baxter.;BD;Gerresheimer AG;辉瑞公司;SCHOTT AG;礼来公司;Sandoz International GmbH;Terumo Corporation;Teva Pharmaceutical Industries Ltd.;Crossject;Amcor plc;AptarGroup, Inc.;Credence MedSystems, Inc.;West Pharmaceutical Services, Inc.;Ypsomed AG;Consort Medical plc;Antares Pharma Inc.;Sensile Medical AG;SHL Medical AG;赛诺菲;以及其他国内和全球参与者。市场份额数据分别针对全球、北美、欧洲、亚太地区 (APAC)、中东和非洲 (MEA) 和南美提供。DBMR 分析师了解竞争优势并为每个竞争对手分别提供竞争分析。


SKU-

Get online access to the report on the World's First Market Intelligence Cloud

  • Interactive Data Analysis Dashboard
  • Company Analysis Dashboard for high growth potential opportunities
  • Research Analyst Access for customization & queries
  • Competitor Analysis with Interactive dashboard
  • Latest News, Updates & Trend analysis
  • Harness the Power of Benchmark Analysis for Comprehensive Competitor Tracking
Request for Demo

研究方法

Data collection and base year analysis are done using data collection modules with large sample sizes. The stage includes obtaining market information or related data through various sources and strategies. It includes examining and planning all the data acquired from the past in advance. It likewise envelops the examination of information inconsistencies seen across different information sources. The market data is analysed and estimated using market statistical and coherent models. Also, market share analysis and key trend analysis are the major success factors in the market report. To know more, please request an analyst call or drop down your inquiry.

The key research methodology used by DBMR research team is data triangulation which involves data mining, analysis of the impact of data variables on the market and primary (industry expert) validation. Data models include Vendor Positioning Grid, Market Time Line Analysis, Market Overview and Guide, Company Positioning Grid, Patent Analysis, Pricing Analysis, Company Market Share Analysis, Standards of Measurement, Global versus Regional and Vendor Share Analysis. To know more about the research methodology, drop in an inquiry to speak to our industry experts.

可定制

Data Bridge Market Research is a leader in advanced formative research. We take pride in servicing our existing and new customers with data and analysis that match and suits their goal. The report can be customized to include price trend analysis of target brands understanding the market for additional countries (ask for the list of countries), clinical trial results data, literature review, refurbished market and product base analysis. Market analysis of target competitors can be analyzed from technology-based analysis to market portfolio strategies. We can add as many competitors that you require data about in the format and data style you are looking for. Our team of analysts can also provide you data in crude raw excel files pivot tables (Fact book) or can assist you in creating presentations from the data sets available in the report.

Frequently Asked Questions

The Injection Devices for Biological Drugs Market is projected to grow at a CAGR of 12.58% during the forecast period by 2028.
The future market value of the Injection Devices for Biological Drugs Market is expected to reach USD 734.35 billion by 2028.
The major players in the Injection Devices for Biological Drugs Market are Baxter.; BD; Gerresheimer AG; Pfizer Inc.; SCHOTT AG; Eli Lilly and Company.; Sandoz International GmbH; Terumo Corporation; Teva Pharmaceutical Industries Ltd.; etc.
The countries covered in the Injection Devices for Biological Drugs Market are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, etc.